Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Cormedix

Clinical trials sponsored by Cormedix, explained in plain language.

Cormedix CRMD NASDAQ

Biopharmaceutical company developing therapies for inflammatory and infectious diseases.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Not yet finished but already full! 1

New hope for catheter patients: expanded access to Infection-Fighting drug DefenCath

Prevention NO_LONGER_AVAILABLE

This expanded access program offers DefenCath, a catheter lock solution containing taurolidine and heparin, to adult and pediatric patients who need a catheter but cannot join ongoing clinical trials or do not meet the current FDA-approved label. The goal is to prevent central li…

Sponsor: CorMedix • Aim: Prevention

Last updated Jul 03, 2026 00:00 UTC